Recent advances of redox-responsive nanoplatforms for tumor theranostics
Authors:
- 1 April 2021
- journal article
- review article
- Published by Elsevier in Journal of Controlled Release
- Vol. 332, 269-284
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 111 references indexed in Scilit:
- Intracellular Antioxidants Dissolve Man-Made Antioxidant Nanoparticles: Using Redox Vulnerability of Nanoceria to Develop a Responsive Drug Delivery SystemACS Applied Materials & Interfaces, 2014
- The Clinical Importance of Assessing Tumor Hypoxia: Relationship of Tumor Hypoxia to Prognosis and Therapeutic OpportunitiesAntioxidants & Redox Signaling, 2014
- pH dependent catalytic activities of platinum nanoparticles with respect to the decomposition of hydrogen peroxide and scavenging of superoxide and singlet oxygenNanoscale, 2014
- Janus-Faced Tumor Microenvironment and RedoxAntioxidants & Redox Signaling, 2014
- Hydrogen peroxide-responsive copolyoxalate nanoparticles for detection and therapy of ischemia–reperfusion injuryJournal of Controlled Release, 2013
- Hydrogen Peroxide Inducible DNA Cross-Linking Agents: Targeted Anticancer ProdrugsJournal of the American Chemical Society, 2011
- Glutathione-responsive nano-vehicles as a promising platform for targeted intracellular drug and gene deliveryJournal of Controlled Release, 2011
- Dual Redox Responsive Assemblies Formed from Diselenide Block CopolymersJournal of the American Chemical Society, 2009
- Matrix metalloproteinases as modulators of inflammation and innate immunityNature Reviews Immunology, 2004
- Oxidation-responsive polymeric vesiclesNature Materials, 2004